Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE.
Talbot K, et al. Among authors: wolf ba.
J Clin Invest. 2012 Apr;122(4):1316-38. doi: 10.1172/JCI59903.
J Clin Invest. 2012.
PMID: 22476197
Free PMC article.